Literature DB >> 25666657

Consumption of orange fermented beverage reduces cardiovascular risk factors in healthy mice.

Blanca Escudero-López1, Genoveva Berná2, Ángeles Ortega2, Griselda Herrero-Martín1, Isabel Cerrillo3, Franz Martín2, María-Soledad Fernández-Pachón4.   

Abstract

The consumption of fruits prevents the risk of cardiovascular diseases. Alcoholic fermentation has been carried out in fruits resulting in products which provide high concentration of bioactive compounds and variable alcohol content. The aim of this study was to assess the potential beneficial effect of an orange beverage obtained by alcoholic fermentation and pasteurization of orange juice on cardiovascular risk biomarkers. For this purpose, four mice groups (n = 8) ingested orange beverage (equivalent volume to 250 mL/day in human), orange juice, alcoholic solution (at the proportional amount of orange beverage) or water during 12 weeks. The equivalent amount to double serving of orange beverage (500 mL/day) was administered to mice in a subsequent intervention, and a control group was also evaluated. Orange beverage consumption increased levels of glutathione and uric acid, improved lipid profile, decreased oxidized LDL and maintained levels of IL-6 and C-reactive protein. Synergistic effects between the bioactive compounds and the alcohol content of orange beverage may occur. The intake of double serving also increased antioxidant enzyme activities, bilirubin content and plasma antioxidant capacity. These results suggest that orange beverage may produce greater protection against cardiovascular risk factors than orange juice in healthy mice.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidant status; Cardiovascular risk; Fermented orange; Inflammation; Lipids

Mesh:

Substances:

Year:  2015        PMID: 25666657     DOI: 10.1016/j.fct.2015.02.006

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

Review 1.  Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.

Authors:  Yang Yang; Myah Trevethan; Shu Wang; Ling Zhao
Journal:  J Nutr Biochem       Date:  2022-02-18       Impact factor: 6.117

2.  Effect of Acute Intake of Fermented Orange Juice on Fasting and Postprandial Glucose Metabolism, Plasma Lipids and Antioxidant Status in Healthy Human.

Authors:  Blanca Escudero-López; Isabel Cerrillo; Ángeles Ortega; Franz Martín; María-Soledad Fernández-Pachón
Journal:  Foods       Date:  2022-04-27

3.  Improving the quality of matured coconut (Cocos nucifera Linn.) water by low alcoholic fermentation with Saccharomyces cerevisiae: antioxidant and volatile profiles.

Authors:  Guanfei Zhang; Wenxue Chen; Weijun Chen; Haiming Chen
Journal:  J Food Sci Technol       Date:  2018-02-06       Impact factor: 2.701

4.  Evaluation of a strawberry fermented beverage with potential health benefits.

Authors:  Zhiqiao Zhao; Xulong Wu; Hong Chen; Yuntao Liu; Yirong Xiao; Hui Chen; Zizhong Tang; Qingfeng Li; Huipeng Yao
Journal:  PeerJ       Date:  2021-08-23       Impact factor: 2.984

Review 5.  Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions.

Authors:  Priyanka Saha; Subhankar Bose; Amit Kumar Srivastava; Anis Ahmad Chaudhary; Rajiv Lall; Sahdeo Prasad
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

6.  Antioxidant and Anti-Inflammatory Effects of Orange Juice.

Authors:  Paula Felippe Martinez; Marianna Rabelo de Carvalho; Maria Lua Marques Mendonça; Marina Politi Okoshi; Silvio Assis de Oliveira-Junior
Journal:  Arq Bras Cardiol       Date:  2021-06       Impact factor: 2.000

7.  Use of Nanovesicles from Orange Juice to Reverse Diet-Induced Gut Modifications in Diet-Induced Obese Mice.

Authors:  Emmanuelle Berger; Pascal Colosetti; Audrey Jalabert; Emmanuelle Meugnier; Oscar P B Wiklander; Juliette Jouhet; Elisabeth Errazurig-Cerda; Stéphanie Chanon; Dhanu Gupta; Gilles J P Rautureau; Alain Geloen; Samir El-Andaloussi; Baptiste Panthu; Jennifer Rieusset; Sophie Rome
Journal:  Mol Ther Methods Clin Dev       Date:  2020-08-14       Impact factor: 6.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.